Cargando…

Cyclic RGD-conjugated Pluronic(®) blending system for active, targeted drug delivery

BACKGROUND: Blending micellar systems of different types of polymers has been proposed as an efficient approach for tailor-made drug formulations. The lamellar structure of hydrophobic polymers may provide a high drug loading capacity, and hydrophilic polymers may provide good colloidal stability. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Chaemin, Moon, Junseong, Sim, Taehoon, Hoang, Ngoc Ha, Won, Woong Roeck, Lee, Eun Seong, Youn, Yu Seok, Choi, Han-Gon, Oh, Kyungsoo, Oh, Kyung Taek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091488/ https://www.ncbi.nlm.nih.gov/pubmed/30127610 http://dx.doi.org/10.2147/IJN.S171794

Ejemplares similares

A nano-sized blending system comprising identical triblock copolymers with different hydrophobicity for fabrication of an anticancer drug nanovehicle with high stability and solubilizing capacity
por: Hoang, Ngoc Ha, et al.
Publicado: (2019)

Development of a robust pH-sensitive polyelectrolyte ionomer complex for anticancer nanocarriers
por: Lim, Chaemin, et al.
Publicado: (2016)

A charge-reversible nanocarrier using PEG-PLL (-g-Ce6, DMA)-PLA for photodynamic therapy
por: Lim, Chaemin, et al.
Publicado: (2017)

An On-Demand pH-Sensitive Nanocluster for Cancer Treatment by Combining Photothermal Therapy and Chemotherapy
por: Sim, Taehoon, et al.
Publicado: (2020)

Development of AE147 Peptide-Conjugated Nanocarriers for Targeting uPAR-Overexpressing Cancer Cells
por: Park, June Yong, et al.
Publicado: (2021)

Development of a docetaxel micellar formulation using poly(ethylene glycol)–polylactide–poly(ethylene glycol) (PEG–PLA–PEG) with successful reconstitution for tumor targeted drug delivery
por: Sim, Taehoon, et al.
Publicado: (2018)

RGD Peptides-Conjugated Pluronic Triblock Copolymers Encapsulated with AP-2α Expression Plasmid for Targeting Gastric Cancer Therapy in Vitro and in Vivo
por: Wang, Wei, et al.
Publicado: (2015)

Low-Molecular Weight Polyethylenimine Modified with Pluronic 123 and RGD- or Chimeric RGD-NLS Peptide: Characteristics and Transfection Efficacy of Their Complexes with Plasmid DNA
por: Hu, Jing, et al.
Publicado: (2016)

Alendronate/cRGD-Decorated Ultrafine Hyaluronate Dot Targeting Bone Metastasis
por: Lee, Eunsol, et al.
Publicado: (2020)

Novel Bifunctional Cyclic Chelator for (89)Zr Labeling–Radiolabeling and Targeting Properties of RGD Conjugates
por: Zhai, Chuangyan, et al.
Publicado: (2015)

Density-tunable conjugation of cyclic RGD ligands with polyion complex vesicles for the neovascular imaging of orthotopic glioblastomas
por: Kawamura, Wataru, et al.
Publicado: (2015)

Molecular Magnetic Resonance Imaging of Angiogenesis In Vivo using Polyvalent Cyclic RGD-Iron Oxide Microparticle Conjugates
por: Melemenidis, Stavros, et al.
Publicado: (2015)

Effect of multiple cyclic RGD peptides on tumor accumulation and intratumoral distribution of IRDye 700DX-conjugated polymers
por: Dou, Xuebo, et al.
Publicado: (2018)

Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma
por: Redko, Boris, et al.
Publicado: (2016)

Modeling of Biological Activity of PEO-Coated Titanium Implants with Conjugates of Cyclic RGD Peptide with Amino Acid Bisphosphonates
por: Parfenova, Lyudmila V., et al.
Publicado: (2022)

Radiolabeled cyclic RGD peptides as radiotracers for tumor imaging
por: Shi, Jiyun, et al.
Publicado: (2016)

Evaluating the Usefulness of a Novel (10)B-Carrier Conjugated With Cyclic RGD Peptide in Boron Neutron Capture Therapy
por: Masunaga, Shin-ichiro, et al.
Publicado: (2012)

Targeted Delivery of FLT-Morpholino Using Cyclic RGD Peptide
por: Uehara, Hironori, et al.
Publicado: (2017)

An Efficient Bivalent Cyclic RGD-PIK3CB siRNA Conjugate for Specific Targeted Therapy against Glioblastoma In Vitro and In Vivo
por: Cen, Bohong, et al.
Publicado: (2018)

Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT
por: Zhou, Yang, et al.
Publicado: (2011)

Synthesis and Biological Characterization of Monomeric and Tetrameric RGD‐Cryptophycin Conjugates
por: Borbély, Adina, et al.
Publicado: (2020)

Linker Hydrophilicity Modulates the Anticancer Activity of RGD–Cryptophycin Conjugates
por: Anselmi, Michele, et al.
Publicado: (2020)

Co-delivery of D-(KLAKLAK)(2) Peptide and Chlorin e6 using a Liposomal Complex for Synergistic Cancer Therapy
por: Lim, Chaemin, et al.
Publicado: (2019)

Effects of PEG-Linker Chain Length of Folate-Linked Liposomal Formulations on Targeting Ability and Antitumor Activity of Encapsulated Drug
por: Lim, Chaemin, et al.
Publicado: (2023)

Targeted therapy for glioma using cyclic RGD-entrapped polyionic complex nanomicelles
por: Liu, Xiaoying, et al.
Publicado: (2012)

Cyclic RGD-Decorated Liposomal Gossypol AT-101 Targeting for Enhanced Antitumor Effect
por: Liu, Hao, et al.
Publicado: (2022)

FITC-Conjugated Cyclic RGD Peptides as Fluorescent Probes for Staining Integrin α(v)β(3)/α(v)β(5) in Tumor Tissues
por: Zheng, Yumin, et al.
Publicado: (2014)

Synergistic Pro-Apoptotic Effect of a Cyclic RGD Peptide-Conjugated Magnetic Mesoporous Therapeutic Nanosystem on Hepatocellular Carcinoma HepG2 Cells
por: Zhao, Xuanping, et al.
Publicado: (2023)

Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery
por: Borbély, Adina, et al.
Publicado: (2019)

Synthesis and Biological Evaluation of RGD–Cryptophycin Conjugates for Targeted Drug Delivery
por: Borbély, Adina, et al.
Publicado: (2019)

An iRGD peptide conjugated heparin nanocarrier for gastric cancer therapy
por: Ai, Shichao, et al.
Publicado: (2018)

Linear, Non-Conjugated Cyclic and Conjugated Cyclic Paraphenylene under Pressure
por: Peña-Álvarez, Miriam, et al.
Publicado: (2019)

Pluronic F-127/Silk Fibroin for Enhanced Mechanical Property and Sustained Release Drug for Tissue Engineering Biomaterial
por: Youn, Jina, et al.
Publicado: (2021)

DPD Study on the Interfacial Properties of PEO/PEO-PPO-PEO/PPO Ternary Blends: Effects of Pluronic Structure and Concentration
por: Liu, Dongmei, et al.
Publicado: (2021)

Pluronics and MDR Reversal: An Update
por: Alakhova, Daria Y., et al.
Publicado: (2014)

The therapeutic effect of methotrexate-conjugated Pluronic-based polymeric micelles on the folate receptor-rich tumors treatment
por: Chen, Yanzuo, et al.
Publicado: (2015)

Preparation of pH Sensitive Pluronic-Docetaxel Conjugate Micelles to Balance the Stability and Controlled Release Issues
por: Liang, Yanchao, et al.
Publicado: (2015)

Transferrin-Conjugated pH-Responsive γ-Cyclodextrin Nanoparticles for Antitumoral Topotecan Delivery
por: Yoon, Seonyoung, et al.
Publicado: (2020)

The Therapeutic Effect of Methotrexate-Conjugated Pluronic-Based Polymeric Micelles on the Folate Receptor-Rich Tumors Treatment [Retraction]
Publicado: (2022)

A bivalent cyclic RGD–siRNA conjugate enhances the antitumor effect of apatinib via co-inhibiting VEGFR2 in non-small cell lung cancer xenografts
por: Liao, Lumin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qgie768v6g8bgttd40v0nb0osr